Global: Early stage funding for healthcare companies remains enthusiastic

Funding for early-stage companies remains enthusiastic with healthcare startups around the world able to raise capital. The largest recent deal, indeed the largest healthtech fundraising in Southeast Asia to date, has come from Singapore-based digital therapeutics company Biofourmis which has raised US$100 million in Series C funding. The round was led by SoftBank Vision Fund…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »